Beverley A. Wynne

938 total citations
6 papers, 724 citations indexed

About

Beverley A. Wynne is a scholar working on Infectious Diseases, Epidemiology and Organic Chemistry. According to data from OpenAlex, Beverley A. Wynne has authored 6 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Epidemiology and 3 papers in Organic Chemistry. Recurrent topics in Beverley A. Wynne's work include Tuberculosis Research and Epidemiology (5 papers), Mycobacterium research and diagnosis (5 papers) and Quinazolinone synthesis and applications (3 papers). Beverley A. Wynne is often cited by papers focused on Tuberculosis Research and Epidemiology (5 papers), Mycobacterium research and diagnosis (5 papers) and Quinazolinone synthesis and applications (3 papers). Beverley A. Wynne collaborates with scholars based in United States, Australia and South Sudan. Beverley A. Wynne's co-authors include Linda Byrd, Paul Southern, Stephen D. Nightingale, Paul M. Sullam, Fred M. Gordin, C. Robert Horsburgh, David L. Cohn, Allen Erenberg, Dennis Haack and Richard D. Leff and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and The American Journal of the Medical Sciences.

In The Last Decade

Beverley A. Wynne

6 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beverley A. Wynne United States 6 579 473 124 100 76 6 724
Isabelle Durand-Joly France 16 667 1.2× 507 1.1× 56 0.5× 48 0.5× 14 0.2× 27 750
T Gorsuch United Kingdom 6 795 1.4× 638 1.3× 126 1.0× 83 0.8× 358 4.7× 8 911
Raymond F. Corpe United Kingdom 11 348 0.6× 271 0.6× 139 1.1× 45 0.5× 67 0.9× 35 457
R. J. Wallace United States 13 684 1.2× 435 0.9× 158 1.3× 64 0.6× 417 5.5× 16 879
Guillermina A. Melendi United States 13 620 1.1× 335 0.7× 88 0.7× 245 2.5× 3 0.0× 14 920
P Ormerod United Kingdom 11 856 1.5× 755 1.6× 282 2.3× 114 1.1× 359 4.7× 24 1.1k
Rhonda E Colombo United States 10 381 0.7× 261 0.6× 43 0.3× 30 0.3× 194 2.6× 44 535
J Wedgwood Switzerland 12 361 0.6× 69 0.1× 67 0.5× 241 2.4× 4 0.1× 13 766
Gavin Corcoran United States 7 919 1.6× 1.0k 2.1× 19 0.2× 43 0.4× 165 2.2× 8 1.1k
D. C. Turk United Kingdom 13 371 0.6× 113 0.2× 52 0.4× 112 1.1× 4 0.1× 30 674

Countries citing papers authored by Beverley A. Wynne

Since Specialization
Citations

This map shows the geographic impact of Beverley A. Wynne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverley A. Wynne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverley A. Wynne more than expected).

Fields of papers citing papers by Beverley A. Wynne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverley A. Wynne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverley A. Wynne. The network helps show where Beverley A. Wynne may publish in the future.

Co-authorship network of co-authors of Beverley A. Wynne

This figure shows the co-authorship network connecting the top 25 collaborators of Beverley A. Wynne. A scholar is included among the top collaborators of Beverley A. Wynne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverley A. Wynne. Beverley A. Wynne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Erenberg, Allen, et al.. (2000). Caffeine Citrate for the Treatment of Apnea of Prematurity: A Double‐Blind, Placebo‐Controlled Study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(6). 644–652. 105 indexed citations
2.
Gordin, Fred M., Paul M. Sullam, Stephen D. Shafran, et al.. (1999). A Randomized, Placebo‐Controlled Study of Rifabutin Added to a Regimen of Clarithromycin and Ethambutol for Treatment of Disseminated Infection with Mycobacterium avium Complex. Clinical Infectious Diseases. 28(5). 1080–1085. 92 indexed citations
3.
Gordin, Fred M., David L. Cohn, Paul M. Sullam, et al.. (1997). Early Manifestations of DisseminatedMycobacterium aviumComplex Disease: A Prospective Evaluation. The Journal of Infectious Diseases. 176(1). 126–132. 35 indexed citations
4.
Horsburgh, C. Robert, John R. Schoenfelder, Fred M. Gordin, et al.. (1997). Geographic and Seasonal Variation in Mycobacterium avium Bacteremia Among North American Patients With AIDS. The American Journal of the Medical Sciences. 313(6). 341–345. 10 indexed citations
5.
Sullam, Paul M., et al.. (1994). Efficacy of Rifabutin in the Treatment of Disseminated Infection Due to Mycobacterium avium Complex. Clinical Infectious Diseases. 19(1). 84–86. 44 indexed citations
6.
Nightingale, Stephen D., et al.. (1992). Incidence of Mycobacterium avium-intracellulare Complex Bacteremia in Human Immunodeficiency Virus-Positive Patients. The Journal of Infectious Diseases. 165(6). 1082–1085. 438 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026